These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
77-0259 335
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
|
|
|
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
|
Emerging growth company
|
¨
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
PART I: FINANCIAL INFORMATION
|
|
|
|
|
|
Item 1. Financial Statements (unaudited)
|
|
|
|
|
|
|
|
|
|
March 31,
2018 |
|
December 30,
2017 |
||||
|
ASSETS
|
|||||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
144,501
|
|
|
$
|
128,635
|
|
|
Short term investments
|
39,960
|
|
|
37,225
|
|
||
|
Accounts receivable, net
|
69,532
|
|
|
142,829
|
|
||
|
Inventory
|
112,111
|
|
|
106,932
|
|
||
|
Other current assets
|
24,584
|
|
|
19,105
|
|
||
|
Total current assets
|
390,688
|
|
|
434,726
|
|
||
|
Property and equipment, net
|
47,223
|
|
|
44,579
|
|
||
|
Deferred tax assets
|
32,690
|
|
|
31,531
|
|
||
|
Goodwill
|
123,218
|
|
|
121,440
|
|
||
|
Intangible assets, net
|
40,613
|
|
|
44,712
|
|
||
|
Other assets
|
15,005
|
|
|
14,534
|
|
||
|
Total assets
|
$
|
649,437
|
|
|
$
|
691,522
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
69,119
|
|
|
$
|
116,316
|
|
|
Accrued expenses
|
56,107
|
|
|
73,647
|
|
||
|
Deferred revenue and customer advances
|
6,271
|
|
|
7,761
|
|
||
|
Total current liabilities
|
131,497
|
|
|
197,724
|
|
||
|
Deferred tax liabilities
|
8,349
|
|
|
9,539
|
|
||
|
Other long-term liabilities
|
12,963
|
|
|
13,932
|
|
||
|
Total long-term liabilities
|
21,312
|
|
|
23,471
|
|
||
|
Total liabilities
|
152,809
|
|
|
221,195
|
|
||
|
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
|
Preferred stock, 5,000 shares authorized and none outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value, 100,000 shares authorized; 28,073 and 27,945
shares issued and outstanding at March 31, 2018 and December 30, 2017, respectively |
280
|
|
|
279
|
|
||
|
Additional paid-in capital
|
191,021
|
|
|
190,067
|
|
||
|
Retained earnings
|
299,430
|
|
|
277,989
|
|
||
|
Accumulated other comprehensive income
|
5,897
|
|
|
1,992
|
|
||
|
Total stockholders’ equity
|
496,628
|
|
|
470,327
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
649,437
|
|
|
$
|
691,522
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
Revenue
|
$
|
217,068
|
|
|
$
|
168,467
|
|
|
Cost of revenue:
|
|
|
|
||||
|
Cost of product revenue
|
96,501
|
|
|
80,260
|
|
||
|
Amortization of intangible assets
|
4,782
|
|
|
864
|
|
||
|
Total cost of revenue (1)
|
101,283
|
|
|
81,124
|
|
||
|
Gross margin
|
115,785
|
|
|
87,343
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
Research and development (1)
|
32,945
|
|
|
25,508
|
|
||
|
Selling and marketing (1)
|
31,329
|
|
|
22,575
|
|
||
|
General and administrative (1)
|
25,833
|
|
|
17,622
|
|
||
|
Amortization of intangible assets
|
273
|
|
|
—
|
|
||
|
Total operating expenses
|
90,380
|
|
|
65,705
|
|
||
|
Operating income
|
25,405
|
|
|
21,638
|
|
||
|
Other income, net
|
519
|
|
|
3
|
|
||
|
Income before income taxes
|
25,924
|
|
|
21,641
|
|
||
|
Income tax expense
|
5,523
|
|
|
5,282
|
|
||
|
Net income
|
$
|
20,401
|
|
|
$
|
16,359
|
|
|
Net income per share:
|
|
|
|
||||
|
Basic
|
$
|
0.73
|
|
|
$
|
0.60
|
|
|
Diluted
|
$
|
0.71
|
|
|
$
|
0.58
|
|
|
Number of weighted average common shares used in per share calculations
|
|
|
|
||||
|
Basic
|
27,988
|
|
|
27,304
|
|
||
|
Diluted
|
28,923
|
|
|
28,295
|
|
||
|
(1)
|
Stock-based compensation recorded in the three months ended
March 31, 2018
and
April 1, 2017
breaks down by expense classification as follows:
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
Cost of revenue
|
$
|
341
|
|
|
$
|
226
|
|
|
Research and development
|
1,689
|
|
|
1,099
|
|
||
|
Selling and marketing
|
738
|
|
|
570
|
|
||
|
General and administrative
|
3,178
|
|
|
2,436
|
|
||
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
Net income
|
$
|
20,401
|
|
|
$
|
16,359
|
|
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Net foreign currency translation adjustments
|
5,338
|
|
|
(52
|
)
|
||
|
Net unrealized losses on cash flow hedges, net of tax
|
(1,851
|
)
|
|
—
|
|
||
|
Net losses on cash flow hedge reclassified into earnings, net of tax
|
590
|
|
|
—
|
|
||
|
Net unrealized gains (losses) on marketable securities, net of tax
|
(172
|
)
|
|
35
|
|
||
|
Total comprehensive income
|
$
|
24,306
|
|
|
$
|
16,342
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
2018 |
|
April 1,
2017 |
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income
|
$
|
20,401
|
|
|
$
|
16,359
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
8,747
|
|
|
3,486
|
|
||
|
Stock-based compensation
|
5,946
|
|
|
4,331
|
|
||
|
Deferred income taxes, net
|
(3,061
|
)
|
|
17
|
|
||
|
Non-cash director deferred compensation
|
16
|
|
|
16
|
|
||
|
Deferred rent
|
1,077
|
|
|
—
|
|
||
|
Other
|
390
|
|
|
166
|
|
||
|
Changes in operating assets and liabilities — (use) source
|
|
|
|
||||
|
Accounts receivable
|
73,642
|
|
|
25,155
|
|
||
|
Inventory
|
(4,223
|
)
|
|
(6,546
|
)
|
||
|
Other assets
|
(6,114
|
)
|
|
(1,745
|
)
|
||
|
Accounts payable
|
(46,461
|
)
|
|
(5,026
|
)
|
||
|
Accrued expenses
|
(19,693
|
)
|
|
(8,612
|
)
|
||
|
Deferred revenue and customer advances
|
(517
|
)
|
|
(284
|
)
|
||
|
Long term liabilities
|
(360
|
)
|
|
(558
|
)
|
||
|
Net cash provided by operating activities
|
29,790
|
|
|
26,759
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Additions of property and equipment
|
(8,717
|
)
|
|
(3,008
|
)
|
||
|
Change in other assets
|
379
|
|
|
(504
|
)
|
||
|
Purchases of investments
|
(6,438
|
)
|
|
(3,498
|
)
|
||
|
Sales and maturities of investments
|
3,500
|
|
|
3,500
|
|
||
|
Net cash used in investing activities
|
(11,276
|
)
|
|
(3,510
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Income tax withholding payment associated with restricted stock vesting
|
(3,478
|
)
|
|
(2,778
|
)
|
||
|
Proceeds from stock option exercises
|
399
|
|
|
722
|
|
||
|
Net cash used in financing activities
|
(3,079
|
)
|
|
(2,056
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
431
|
|
|
12
|
|
||
|
Net increase in cash and cash equivalents
|
15,866
|
|
|
21,205
|
|
||
|
Cash and cash equivalents, at beginning of period
|
128,635
|
|
|
214,523
|
|
||
|
Cash and cash equivalents, at end of period
|
$
|
144,501
|
|
|
$
|
235,728
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Cash paid for income taxes
|
$
|
4,660
|
|
|
$
|
5,563
|
|
|
Non-cash investing and financing activities:
|
|
|
|
||||
|
Additions of property and equipment included in accounts payable
|
$
|
3,003
|
|
|
$
|
2,461
|
|
|
|
Three Months Ended
|
||||||
|
|
(In thousands, except per share amounts)
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
Net income
|
$
|
20,401
|
|
|
$
|
16,359
|
|
|
Weighted-average common shares outstanding
|
27,988
|
|
|
27,304
|
|
||
|
Dilutive effect of employee stock options and restricted shares
|
935
|
|
|
991
|
|
||
|
Diluted weighted-average common shares outstanding
|
28,923
|
|
|
28,295
|
|
||
|
Basic income per share
|
$
|
0.73
|
|
|
$
|
0.60
|
|
|
Diluted income per share
|
$
|
0.71
|
|
|
$
|
0.58
|
|
|
|
Three Months Ended
|
||
|
|
March 31, 2018
|
||
|
Americas
|
$
|
116,649
|
|
|
EMEA
|
65,249
|
|
|
|
APAC
|
35,170
|
|
|
|
Total revenue
|
$
|
217,068
|
|
|
|
March 31, 2018
(closing balance)
|
December 31, 2017
(opening balance)
|
||||
|
Accounts receivable, net
|
$
|
69,532
|
|
$
|
141,637
|
|
|
Contract liabilities
|
6,271
|
|
6,685
|
|
||
|
Cash
|
$
|
37,981
|
|
|
Accounts receivable
|
21,426
|
|
|
|
Inventory
|
36,304
|
|
|
|
Goodwill
|
78,926
|
|
|
|
Intangible assets
|
36,597
|
|
|
|
Other assets
|
2,456
|
|
|
|
Total assets acquired
|
213,690
|
|
|
|
|
|
||
|
Accounts payable
|
(29,391
|
)
|
|
|
Accrued expenses
|
(3,376
|
)
|
|
|
Deferred tax liabilities
|
(10,864
|
)
|
|
|
Other liabilities
|
(645
|
)
|
|
|
Total liabilities assumed
|
(44,276
|
)
|
|
|
Net assets acquired
|
$
|
169,414
|
|
|
|
Useful Life
|
|
Fair Value
|
||
|
|
|
|
(in thousands)
|
||
|
Reacquired distribution rights
|
2.25 years
|
|
$
|
29,296
|
|
|
Customer relationships
|
14 years
|
|
7,029
|
|
|
|
Non-competition agreements
|
3 years
|
|
272
|
|
|
|
Total
|
|
|
$
|
36,597
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
Revenue
|
$
|
217,068
|
|
|
$
|
179,124
|
|
|
Net income
|
20,401
|
|
|
15,647
|
|
||
|
Net income per share:
|
|
|
|
||||
|
Basic income per share
|
$
|
0.73
|
|
|
$
|
0.57
|
|
|
Diluted income per share
|
$
|
0.71
|
|
|
$
|
0.55
|
|
|
|
March 31, 2018
|
|
December 30, 2017
|
||||
|
|
(In thousands)
|
||||||
|
Raw materials
|
$
|
3,853
|
|
|
$
|
4,036
|
|
|
Finished goods
|
108,258
|
|
|
102,896
|
|
||
|
|
$
|
112,111
|
|
|
$
|
106,932
|
|
|
|
(In thousands)
|
||
|
|
|
||
|
Balance as of December 30, 2017
|
$
|
121,440
|
|
|
Purchase accounting adjustments
|
(663
|
)
|
|
|
Effect of foreign currency translation
|
2,441
|
|
|
|
Balance as of March 31, 2018
|
$
|
123,218
|
|
|
|
March 31, 2018
|
|
December 30, 2017
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
|
|
(In thousands)
|
||||||||||||||||||||||
|
Completed technology
|
$
|
26,900
|
|
|
$
|
19,014
|
|
|
$
|
7,886
|
|
|
$
|
26,900
|
|
|
$
|
18,150
|
|
|
$
|
8,750
|
|
|
Tradename
|
100
|
|
|
100
|
|
|
—
|
|
|
100
|
|
|
100
|
|
|
—
|
|
||||||
|
Customer relationships
|
11,766
|
|
|
629
|
|
|
11,137
|
|
|
11,594
|
|
|
418
|
|
|
11,176
|
|
||||||
|
Reacquired distribution rights
|
34,660
|
|
|
13,306
|
|
|
21,354
|
|
|
33,760
|
|
|
9,226
|
|
|
24,534
|
|
||||||
|
Non-competition agreements
|
283
|
|
|
47
|
|
|
236
|
|
|
275
|
|
|
23
|
|
|
252
|
|
||||||
|
Total
|
$
|
73,709
|
|
|
$
|
33,096
|
|
|
$
|
40,613
|
|
|
$
|
72,629
|
|
|
$
|
27,917
|
|
|
$
|
44,712
|
|
|
|
Cost of Revenue
|
|
Operating Expenses
|
|
Total
|
||||||
|
Remainder of 2018
|
$
|
14,368
|
|
|
$
|
821
|
|
|
$
|
15,189
|
|
|
2019
|
12,397
|
|
|
1,091
|
|
|
13,488
|
|
|||
|
2020
|
900
|
|
|
1,067
|
|
|
1,967
|
|
|||
|
2021
|
900
|
|
|
830
|
|
|
1,730
|
|
|||
|
2022
|
675
|
|
|
829
|
|
|
1,504
|
|
|||
|
Thereafter
|
—
|
|
|
6,735
|
|
|
6,735
|
|
|||
|
Total
|
$
|
29,240
|
|
|
$
|
11,373
|
|
|
$
|
40,613
|
|
|
|
March 31, 2018
|
|
December 30, 2017
|
||||
|
|
(In thousands)
|
||||||
|
Accrued compensation
|
$
|
16,387
|
|
|
$
|
29,514
|
|
|
Accrued income taxes
|
12,295
|
|
|
7,110
|
|
||
|
Accrued warranty
|
11,833
|
|
|
11,264
|
|
||
|
Accrued sales and other indirect taxes payable
|
1,861
|
|
|
7,256
|
|
||
|
Accrued sales and marketing
|
1,620
|
|
|
3,299
|
|
||
|
Accrued accounting fees
|
1,540
|
|
|
1,221
|
|
||
|
Accrued direct fulfillment costs
|
790
|
|
|
1,885
|
|
||
|
Accrued other
|
9,781
|
|
|
12,098
|
|
||
|
|
$
|
56,107
|
|
|
$
|
73,647
|
|
|
|
|
|
Fair Value
|
||||||
|
|
Classification
|
|
March 31, 2018
|
|
December 30, 2017
|
||||
|
|
|
(In thousands)
|
|||||||
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|||||
|
Foreign currency forward contracts
|
Other current assets
|
|
$
|
—
|
|
|
$
|
413
|
|
|
Foreign currency forward contracts
|
Accrued expenses
|
|
936
|
|
|
221
|
|
||
|
Derivatives designated as cash flow hedges:
|
|
|
|
|
|||||
|
Foreign currency forward contracts
|
Other current assets
|
|
$
|
131
|
|
|
$
|
488
|
|
|
Foreign currency forward contracts
|
Other assets
|
|
—
|
|
|
116
|
|
||
|
Foreign currency forward contracts
|
Accrued expenses
|
|
1,676
|
|
|
279
|
|
||
|
|
|
|
Three Months Ended
|
||||||
|
|
Classification
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
|
|
|
(In thousands)
|
||||||
|
Gain (loss) recognized in income
|
Other income, net
|
|
$
|
(1,169
|
)
|
|
$
|
(225
|
)
|
|
|
|
|
|
|
|
Effective Portion
|
|
Ineffective Portion
|
||||||||||||||||||||
|
|
|
Gain (loss) recognized in OCI on Derivative (1)
|
|
Gain (loss) reclassified from accumulated OCI into income (2)
|
|
Gain (loss) recognized in income (3)
|
||||||||||||||||||||||
|
|
|
Three months ended
|
|
|
|
Three months ended
|
|
|
|
Three months ended
|
||||||||||||||||||
|
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Classification
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Classification
|
|
March 31, 2018
|
|
April 1, 2017
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign currency forward contracts
|
|
$
|
(2,714
|
)
|
|
$
|
—
|
|
|
Revenue
|
|
$
|
(166
|
)
|
|
$
|
—
|
|
|
Other income, net
|
|
$
|
(78
|
)
|
|
$
|
—
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
$
|
(755
|
)
|
|
$
|
—
|
|
|
|
|
|
|
|
||||||||
|
(1)
|
The amount represents the change in fair value of derivative contracts due to changes in spot rates.
|
|
(2)
|
The amount represents reclassification from other comprehensive income to earnings that occurs when the hedged item affects earnings.
|
|
(3)
|
The amount represents the change in fair value of derivative contracts due to changes in the forward rates. No gains or losses were reclassified as a result of discontinuance of cash flow hedges.
|
|
|
Fair Value Measurements as of
March 31, 2018
|
||||||||||
|
|
Level 1
|
|
Level 2 (1)
|
|
Level 3
|
||||||
|
|
(In thousands)
|
||||||||||
|
Assets:
|
|
|
|
|
|
||||||
|
Money market funds
|
$
|
60,452
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Corporate and government bonds, $40,686 at cost (2)
|
—
|
|
|
39,960
|
|
|
—
|
|
|||
|
Derivative instruments (Note 8)
|
—
|
|
|
131
|
|
|
—
|
|
|||
|
Total assets measured at fair value
|
$
|
60,452
|
|
|
$
|
40,091
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
||||||
|
Liabilities:
|
|
|
|
|
|
||||||
|
Derivative instruments (Note 8)
|
$
|
—
|
|
|
$
|
2,612
|
|
|
$
|
—
|
|
|
Total liabilities measured at fair value
|
$
|
—
|
|
|
$
|
2,612
|
|
|
$
|
—
|
|
|
|
Fair Value Measurements as of
December 30, 2017 |
||||||||||
|
|
Level 1
|
|
Level 2 (1)
|
|
Level 3
|
||||||
|
|
(In thousands)
|
||||||||||
|
Assets:
|
|
|
|
|
|
||||||
|
Money market funds
|
$
|
3,165
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Corporate and government bonds, $37,767 at cost (2)
|
—
|
|
|
37,225
|
|
|
—
|
|
|||
|
Derivative instruments (Note 8)
|
—
|
|
|
1,017
|
|
|
—
|
|
|||
|
Total assets measured at fair value
|
$
|
3,165
|
|
|
$
|
38,242
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
||||||
|
Liabilities:
|
|
|
|
|
|
||||||
|
Derivative instruments (Note 8)
|
$
|
—
|
|
|
$
|
500
|
|
|
$
|
—
|
|
|
Total liabilities measured at fair value
|
$
|
—
|
|
|
$
|
500
|
|
|
$
|
—
|
|
|
(1)
|
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
|
|
(2)
|
As of
March 31, 2018
, the Company’s investments had maturity dates ranging from June 2018 to March 2021.
|
|
|
Operating
Leases
|
||
|
|
(In thousands)
|
||
|
Remainder of 2018
|
$
|
5,042
|
|
|
2019
|
7,715
|
|
|
|
2020
|
7,370
|
|
|
|
2021
|
7,362
|
|
|
|
2022
|
7,287
|
|
|
|
Thereafter
|
41,893
|
|
|
|
Total minimum lease payments
|
$
|
76,669
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||||
|
|
(In thousands)
|
||||||
|
Balance at beginning of period
|
$
|
11,264
|
|
|
$
|
8,464
|
|
|
Provision
|
2,435
|
|
|
1,994
|
|
||
|
Warranty usage (1)
|
(1,866
|
)
|
|
(1,730
|
)
|
||
|
Balance at end of period
|
$
|
11,833
|
|
|
$
|
8,728
|
|
|
(1)
|
Warranty usage includes costs incurred for warranty obligations.
|
|
|
Three Months Ended
|
||||
|
|
March 31, 2018
|
|
April 1, 2017
|
||
|
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenue:
|
|
|
|
||
|
Cost of product revenue
|
44.5
|
|
|
47.7
|
|
|
Amortization of intangible assets
|
2.2
|
|
|
0.5
|
|
|
Total cost of revenue
|
46.7
|
|
|
48.2
|
|
|
Gross margin
|
53.3
|
|
|
51.8
|
|
|
Operating expenses:
|
|
|
|
||
|
Research and development
|
15.2
|
|
|
15.1
|
|
|
Selling and marketing
|
14.4
|
|
|
13.4
|
|
|
General and administrative
|
11.9
|
|
|
10.5
|
|
|
Amortization of intangible assets
|
0.1
|
|
|
—
|
|
|
Total operating expenses
|
41.6
|
|
|
39.0
|
|
|
Operating income
|
11.7
|
|
|
12.8
|
|
|
Other income, net
|
0.2
|
|
|
—
|
|
|
Income before income taxes
|
11.9
|
|
|
12.8
|
|
|
Income tax expense
|
2.5
|
|
|
3.1
|
|
|
Net income
|
9.4
|
%
|
|
9.7
|
%
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
|
|
(In thousands)
|
|
|
||
|
Total revenue
|
$217,068
|
|
$168,467
|
|
$48,601
|
|
28.8%
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Cost of product revenue
|
$96,501
|
|
$80,260
|
|
$16,241
|
|
20.2%
|
|
As a percentage of total revenue
|
44.5%
|
|
47.7%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Total gross margin
|
$115,785
|
|
$87,343
|
|
$28,442
|
|
32.6%
|
|
As a percentage of total revenue
|
53.3%
|
|
51.8%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Total research and development
|
$32,945
|
|
$25,508
|
|
$7,437
|
|
29.2%
|
|
As a percentage of total revenue
|
15.2%
|
|
15.1%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Total selling and marketing
|
$31,329
|
|
$22,575
|
|
$8,754
|
|
38.8%
|
|
As a percentage of total revenue
|
14.4%
|
|
13.4%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Total general and administrative
|
$25,833
|
|
$17,622
|
|
$8,211
|
|
46.6%
|
|
As a percentage of total revenue
|
11.9%
|
|
10.5%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Total amortization of intangible assets
|
$5,055
|
|
$864
|
|
$4,191
|
|
485.1%
|
|
As a percentage of total revenue
|
2.3%
|
|
0.5%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Total other income, net
|
$519
|
|
$3
|
|
$516
|
|
17,200.0%
|
|
As a percentage of total revenue
|
0.2%
|
|
—%
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2018
|
|
April 1, 2017
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
||||||
|
Income tax provision
|
$5,523
|
|
$5,282
|
|
$241
|
|
4.6%
|
|
Effective income tax rate
|
21.3%
|
|
24.4%
|
|
|
|
|
|
|
Total number of Shares Purchased (1)
|
Average Price Paid per Share
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
|
||||||
|
Fiscal month beginning December 31, 2017 and ended January 27, 2018
|
—
|
|
$
|
—
|
|
—
|
|
$
|
—
|
|
|
Fiscal month beginning January 28, 2018 and ended February 24, 2018
|
—
|
|
—
|
|
—
|
|
—
|
|
||
|
Fiscal month beginning February 25, 2018 and ended March 31, 2018
|
30,000
|
|
64.32
|
|
30,000
|
|
48,069,943
|
|
||
|
Total
|
30,000
|
|
$
|
64.32
|
|
30,000
|
|
$
|
48,069,943
|
|
|
(1)
|
Consists of shares of our common stock. All repurchases were made in open market transactions and pursuant to our previously-announced stock repurchase program as further discussed below.
|
|
(2)
|
On February 27, 2018, our board of directors approved a stock repurchase program authorizing up to $50.0 million in share repurchases. This share repurchase program commenced on March 28, 2018 with an expiration date on December 28, 2018.
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
|
|
Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
101*
|
|
The following materials from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, and (v) related notes to these financial statements
|
|
*
|
Filed herewith
|
|
**
|
Furnished herewith
|
|
|
iROBOT CORPORATION
|
|
|
|
|
|
|
Date: May 4, 2018
|
By:
|
/s/ Alison Dean
|
|
|
|
Alison Dean
|
|
|
|
Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|